SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053007
Filing Date
2020-11-10
Accepted
2020-11-10 16:32:40
Documents
75
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20200930.htm   iXBRL 10-Q 3107521
2 EX-31.1 adpt-ex311_45.htm EX-31.1 24790
3 EX-31.2 adpt-ex312_46.htm EX-31.2 26199
4 EX-32.1 adpt-ex321_44.htm EX-32.1 11630
5 EX-32.2 adpt-ex322_43.htm EX-32.2 13084
  Complete submission text file 0001564590-20-053007.txt   10141306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adpt-20200930.xsd EX-101.SCH 59054
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20200930_cal.xml EX-101.CAL 56795
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20200930_def.xml EX-101.DEF 214671
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20200930_lab.xml EX-101.LAB 468049
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20200930_pre.xml EX-101.PRE 375064
11 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20200930_htm.xml XML 1933132
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 201301616
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences